Tetrahydroindolone and tetrahydroindazolone derivatives

Disclosed are compounds and pharmaceutically acceptable salts of Formula (I) : wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , n, Q1, Q2, Q3, Y, and X 1 -X 4 are as defined herein. Compounds of Formula (I) are useful in the treatment of diseases and/or conditions related to cell proliferation, suc...

Full description

Saved in:
Bibliographic Details
Main Authors Hinkley, Lindsay, Eaves, Jeron, Veal, James, Hanson, Gunnar, Geng, Lifeng, Barta, Thomas, Huang, Kenneth He
Format Patent
LanguageEnglish
French
German
Published 12.07.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are compounds and pharmaceutically acceptable salts of Formula (I) : wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , n, Q1, Q2, Q3, Y, and X 1 -X 4 are as defined herein. Compounds of Formula (I) are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
Bibliography:Application Number: EP20110173186